PROVECTUS BIOPHARMS (PVCT) SEC filings
PVCT SEC filings moved a median of 0.00% by the close. PVCT SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PVCT overview →
52 measured PVCT SEC filing events.
Where these PVCT SEC filings landedvs 51 measured PVCT SEC filing reactions
| Middle 50% of PVCT SEC filing reactions | -1.43% to +2.27% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 51 |
Point-in-time · zero look-ahead
Half of the 51 PVCT SEC filing events with a measured close landed between -1.43% and +2.27%; 49% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Jun 30 | SEC filing · Form 10-Q | — | -3.61% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 30 | SEC filing · Form 8-K | -1.43% | -0.57% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 18 | SEC filing · Form 8-K | +1.64% | +7.87% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 18 | SEC filing · Form 8-K | — | +0.16% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Mar 31 | SEC filing · Form 10-Q | — | +2.04% | |
| Form ARS PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form ARS | — | +0.00% | |
| Form DEF 14A PROVECTUS BIOPHARMACEUTI For: Apr 30 | SEC filing · Form DEF | — | +0.00% | |
| Form DEFA14A PROVECTUS BIOPHARMACEUTI | SEC filing · Form DEFA14A | — | +0.00% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Apr 20 | SEC filing · Form 8-K | -2.03% | -2.66% | |
| Form PRE 14A PROVECTUS BIOPHARMACEUTI For: Apr 20 | SEC filing · Form PRE | +7.92% | +7.92% | |
| Form 10-K PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form 10-K | +0.00% | -6.81% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jan 30 | SEC filing · Form 8-K | — | +0.00% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Sep 30 | SEC filing · Form 10-Q | — | — | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Jun 30 | SEC filing · Form 10-Q | — | +0.00% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 18 | SEC filing · Form 8-K | +0.76% | +1.84% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 18 | SEC filing · Form 8-K | -7.15% | -3.00% | |
| Form DEFA14A PROVECTUS BIOPHARMACEUTI | SEC filing · Form DEFA14A | -7.15% | -3.00% | |
| Form 10-K/A PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form 10-K | — | +1.17% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +0.36% | |
| Form ARS PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form ARS | +0.11% | +7.64% | |
| Form DEF 14A PROVECTUS BIOPHARMACEUTI For: Apr 30 | SEC filing · Form DEF | -0.11% | -0.77% | |
| Form DEFA14A PROVECTUS BIOPHARMACEUTI | SEC filing · Form DEFA14A | -0.11% | -0.77% | |
| Form PRE 14A PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form PRE | -6.88% | -6.63% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Apr 15 | SEC filing · Form 8-K | — | +2.78% | |
| Form 10-K PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form 10-K | +0.00% | +5.31% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jan 15 | SEC filing · Form 8-K | — | +0.62% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 20 | SEC filing · Form 8-K | +0.26% | +4.18% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 05 | SEC filing · Form 8-K | -2.06% | +0.46% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Dec 02 | SEC filing · Form 8-K | +0.00% | +12.34% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Nov 14 | SEC filing · Form 8-K | -0.18% | -0.63% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Sep 30 | SEC filing · Form 10-Q | — | +2.02% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Aug 14 | SEC filing · Form 8-K | — | +0.00% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Jun 30 | SEC filing · Form 10-Q | — | +1.01% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jul 11 | SEC filing · Form 8-K | — | +0.00% | |
| Form D PROVECTUS BIOPHARMACEUTI | SEC filing · Form D | +0.00% | -6.25% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 21 | SEC filing · Form 8-K | — | -0.81% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 20 | SEC filing · Form 8-K | — | +4.43% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Jun 20 | SEC filing · Form 8-K | — | -6.08% | |
| Form DEFA14A PROVECTUS BIOPHARMACEUTI | SEC filing · Form DEFA14A | +4.29% | -2.05% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Mar 31 | SEC filing · Form 10-Q | — | +1.38% | |
| Form ARS PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form ARS | — | +3.76% | |
| Form DEF 14A PROVECTUS BIOPHARMACEUTI For: May 06 | SEC filing · Form DEF | — | -7.07% | |
| Form DEFA14A PROVECTUS BIOPHARMACEUTI | SEC filing · Form DEFA14A | — | -7.07% | |
| Form 10-K/A PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form 10-K | — | +2.08% | |
| Form PRE 14A PROVECTUS BIOPHARMACEUTI For: Apr 26 | SEC filing · Form PRE | — | +2.50% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Apr 10 | SEC filing · Form 8-K | -15.59% | +11.77% | |
| Form 10-K PROVECTUS BIOPHARMACEUTI For: Dec 31 | SEC filing · Form 10-K | — | -3.71% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Mar 21 | SEC filing · Form 8-K | — | +0.00% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Mar 25 | SEC filing · Form 8-K | +2.46% | +2.46% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Feb 22 | SEC filing · Form 8-K | +0.00% | +2.04% | |
| Form 8-K PROVECTUS BIOPHARMACEUTI For: Feb 15 | SEC filing · Form 8-K | +0.00% | +4.10% | |
| Form 10-Q PROVECTUS BIOPHARMACEUTI For: Sep 30 | SEC filing · Form 10-Q | — | -2.54% |
Keep exploring
More PVCT: earnings → · analyst actions → · PVCT overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| INNOVATE BIOPHARMACEUTICALS (INNT) | 220 | -0.77% | 38% |
| OWC PHARMS RESEARCH CORP (OWCP) | 220 | +0.09% | 52% |
| TG Therapeutics, Inc. (TGTX) | 220 | -0.06% | 47% |
| Lipocine Inc. (LPCN) | 219 | +0.34% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.